Related Articles
Enhanced hepatocyte growth factor level in human prostate cancer treated with endocrine therapy.
Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue
Expression of hepatocyte growth factor and c-Met in non-small-cell lung cancer and association with lymphangiogenesis
Quantification of MET and hepatocyte growth factor/scatter factor expression in colorectal adenomas, carcinomas and non-neoplastic epithelia by quantitative laser scanning microscopy
MicroRNA‑200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c‑Met signaling pathway